ACA
Avoro Capital Advisors’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $681M | Sell |
2,370,000
-305,000
| -11% | -$87.6M | 11.93% | 2 |
|
|
2025
Q1 | $825M | Sell |
2,675,000
-85,300
| -3% | -$26.3M | 12.87% | 1 |
|
|
2024
Q4 | $974M | Sell |
2,760,300
-98,588
| -3% | -$34.8M | 13.78% | 1 |
|
|
2024
Q3 | $1.02B | Hold |
2,858,888
| – | – | 14.94% | 1 |
|
|
2024
Q2 | $911M | Hold |
2,858,888
| – | – | 12.13% | 1 |
|
|
2024
Q1 | $657M | Hold |
2,858,888
| – | – | 7.66% | 1 |
|
|
2023
Q4 | $629M | Buy |
2,858,888
+6,388
| +0.2% | +$1.4M | 8.68% | 2 |
|
|
2023
Q3 | $644M | Sell |
2,852,500
-57,499
| -2% | -$13M | 10.05% | 2 |
|
|
2023
Q2 | $642M | Buy |
2,909,999
+39,999
| +1% | +$8.83M | 8.71% | 3 |
|
|
2023
Q1 | $643M | Buy |
2,870,000
+5,000
| +0.2% | +$1.12M | 9.53% | 3 |
|
|
2022
Q4 | $797M | Sell |
2,865,000
-61,500
| -2% | -$17.1M | 11.91% | 1 |
|
|
2022
Q3 | $613M | Sell |
2,926,500
-43,500
| -1% | -$9.11M | 11.32% | 2 |
|
|
2022
Q2 | $700M | Sell |
2,970,000
-60,000
| -2% | -$14.1M | 13.83% | 1 |
|
|
2022
Q1 | $544M | Sell |
3,030,000
-5,000
| -0.2% | -$897K | 9.92% | 2 |
|
|
2021
Q4 | $656M | Buy |
3,035,000
+35,000
| +1% | +$7.56M | 11.16% | 3 |
|
|
2021
Q3 | $554M | Hold |
3,000,000
| – | – | 8.7% | 4 |
|
|
2021
Q2 | $538M | Hold |
3,000,000
| – | – | 9.36% | 3 |
|
|
2021
Q1 | $502M | Buy |
3,000,000
+150,000
| +5% | +$25.1M | 8.67% | 3 |
|
|
2020
Q4 | $433M | Buy |
+2,850,000
| New | +$433M | 7.45% | 3 |
|